Represented Oklahoma Medical Research Foundation (OMRF) in a suit against Eli Lilly in the Western District of Oklahoma. OMRF alleged patent infringement and breach of a license agreement in connection with Eli Lilly's sales of Xigris, the first FDA-approved drug to treat severe sepsis. The suit settled on the eve of trial after more than 60 depositions, production of more than one million pages of documents by Eli Lilly, and a Markman hearing resulting in a claim construction favorable to our client.

Oklahoma Med. Research Found. v. Eli Lilly & Co., No. 01-0456 (W.D. Okla. filed Mar. 15, 2001).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Estate of Martin Luther King, Jr., Inc. v. CBS, Inc.
Successfully represented the heirs of Dr. Martin Luther King, Jr. against CBS Broadcasting Inc. in a highly publicized case before the Eleventh more
Environmental counsel to private equity fund investing in redevelopment of contaminated property
Provide environmental counsel to a private equity fund in connection with regulatory, liability transfer and insurance issues relating to the more
China expansion for one of the world's leading providers of lighting fixtures
Represented one of the world's leading providers of lighting fixtures and related products and services in structuring its expanding operations in more
Arbitration for a global supplier of electro-mechanical equipment, systems, and services
The firm served as lead counsel to a global supplier of electro-mechanical equipment, systems, and services in an arbitration where the owner alleged more